Literature DB >> 18794521

Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer.

Brian A Rabinovich1, Yang Ye, Tamara Etto, Jie Qing Chen, Hyam I Levitsky, Willem W Overwijk, Laurence J N Cooper, Juri Gelovani, Patrick Hwu.   

Abstract

Antigen specific T cell migration to sites of infection or cancer is critical for an effective immune response. In mouse models of cancer, the number of lymphocytes reaching the tumor is typically only a few hundred, yet technology capable of imaging these cells using bioluminescence has yet to be achieved. A combination of codon optimization, removal of cryptic splice sites and retroviral modification was used to engineer an enhanced firefly luciferase (ffLuc) vector. Compared with ffLuc, T cells expressing our construct generated >100 times more light, permitting detection of as few as three cells implanted s.c. while maintaining long term coexpression of a reporter gene (Thy1.1). Expression of enhanced ffLuc in mouse T cells permitted the tracking of <3 x 10(4) adoptively transferred T cells infiltrating sites of vaccination and preestablished tumors. Penetration of light through deep tissues, including the liver and spleen, was also observed. Finally, we were able to enumerate infiltrating mouse lymphocytes constituting <0.3% of total tumor cellularity, representing a significant improvement over standard methods of quantitation including flow cytometry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794521      PMCID: PMC2567214          DOI: 10.1073/pnas.0804105105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Bioluminescence imaging of lymphocyte trafficking in vivo.

Authors:  J Hardy; M Edinger; M H Bachmann; R S Negrin; C G Fathman; C H Contag
Journal:  Exp Hematol       Date:  2001-12       Impact factor: 3.084

2.  The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors.

Authors:  B K Helmich; R W Dutton
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 3.  Intravital microscopy: visualizing immunity in context.

Authors:  Cenk Sumen; Thorsten R Mempel; Irina B Mazo; Ulrich H von Andrian
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

Review 4.  Cardiopulmonary toxicity of adoptive immunotherapy.

Authors:  F L Glauser; G DeBlois; D Bechard; A A Fowler; R Merchant; R P Fairman
Journal:  Am J Med Sci       Date:  1988-12       Impact factor: 2.378

Review 5.  Dissecting tumour pathophysiology using intravital microscopy.

Authors:  Rakesh K Jain; Lance L Munn; Dai Fukumura
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

6.  Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis.

Authors:  A Nakajima; C M Seroogy; M R Sandora; I H Tarner; G L Costa; C Taylor-Edwards; M H Bachmann; C H Contag; C G Fathman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

7.  Murine T cells potently restrict human immunodeficiency virus infection.

Authors:  Jörg G Baumann; Derya Unutmaz; Michael D Miller; Sabine K J Breun; Stacy M Grill; Jane Mirro; Dan R Littman; Alan Rein; Vineet N KewalRamani
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells.

Authors:  Brian A Rabinovich; Jennifer Li; John Shannon; Rose Hurren; Jan Chalupny; David Cosman; Richard G Miller
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.

Authors:  Steven A Rosenberg; Mark E Dudley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

10.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Authors:  Matthias Edinger; Petra Hoffmann; Joerg Ermann; Kathryn Drago; C Garrison Fathman; Samuel Strober; Robert S Negrin
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

View more
  104 in total

1.  A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases.

Authors:  Danielle Morse; Bakhos A Tannous
Journal:  Mol Ther       Date:  2012-04       Impact factor: 11.454

Review 2.  A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.

Authors:  Anna J Studwell; Darrell N Kotton
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 3.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

4.  Design and Synthesis of an Alkynyl Luciferin Analogue for Bioluminescence Imaging.

Authors:  Rachel C Steinhardt; Jessica M O'Neill; Colin M Rathbun; David C McCutcheon; Miranda A Paley; Jennifer A Prescher
Journal:  Chemistry       Date:  2016-01-19       Impact factor: 5.236

5.  Mouse model for pre-clinical study of human cancer immunotherapy.

Authors:  Zhiya Ya; Yared Hailemichael; Willem Overwijk; Nicholas P Restifo
Journal:  Curr Protoc Immunol       Date:  2015-02-02

6.  Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

Review 7.  In vivo cell tracking with bioluminescence imaging.

Authors:  Jung Eun Kim; Senthilkumar Kalimuthu; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-11-26

8.  Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64.

Authors:  Parijat Bhatnagar; Zheng Li; Yoonsu Choi; Jianfeng Guo; Feng Li; Daniel Y Lee; Matthew Figliola; Helen Huls; Dean A Lee; Tomasz Zal; King C Li; Laurence J N Cooper
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

9.  Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.

Authors:  Franz J Zemp; Xueqing Lun; Brienne A McKenzie; Hongyuan Zhou; Lori Maxwell; Beichen Sun; John J P Kelly; Owen Stechishin; Artee Luchman; Samuel Weiss; J Gregory Cairncross; Mark G Hamilton; Brian A Rabinovich; Masmudur M Rahman; Mohamed R Mohamed; Sherin Smallwood; Donna L Senger; John Bell; Grant McFadden; Peter A Forsyth
Journal:  Neuro Oncol       Date:  2013-04-12       Impact factor: 12.300

10.  Non-invasive detection of a small number of bioluminescent cancer cells in vivo.

Authors:  Jae-Beom Kim; Konnie Urban; Edward Cochran; Steve Lee; Angel Ang; Bradley Rice; Adam Bata; Kenneth Campbell; Richard Coffee; Alex Gorodinsky; Zhan Lu; He Zhou; Takashi Kei Kishimoto; Peter Lassota
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.